Savulescu proposes that instead of trying to detect whether an athlete has taken drugs, we should focus on measurable indications of whether an athlete is risking his or her health. So, if an athlete has a dangerously high level of red blood cells as a result of taking erythropoietin (EPO), he or she should not be allowed to compete.
Savulescu提议我们应该关注那些显示运动员是否在冒损害健康的风险的可测量指标，而不是检测他们服用了什么药物。因此，如果一名运动员由于服用促红细胞生长素 (EPO)而使红细胞水平高到了危险的程度，那么就不应该允许其参赛。问题的关键是红细胞的指标本身而不是使其提升的手段。